These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
329 related items for PubMed ID: 14973549
1. Treatment of bladder carcinomas using recombinant BCG DNA vaccines and electroporative gene immunotherapy. Lee CF, Chang SY, Hsieh DS, Yu DS. Cancer Gene Ther; 2004 Mar; 11(3):194-207. PubMed ID: 14973549 [Abstract] [Full Text] [Related]
2. Immunotherapy for bladder cancer using recombinant bacillus Calmette-Guerin DNA vaccines and interleukin-12 DNA vaccine. Lee CF, Chang SY, Hsieh DS, Yu DS. J Urol; 2004 Mar; 171(3):1343-7. PubMed ID: 14767345 [Abstract] [Full Text] [Related]
3. Antitumor effects of recombinant BCG and interleukin-12 DNA vaccines on xenografted murine bladder cancer. Yu DS, Lee CF, Hsieh DS, Chang SY. Urology; 2004 Mar; 63(3):596-601. PubMed ID: 15028475 [Abstract] [Full Text] [Related]
6. Induction of effective antitumor immune responses in a mouse bladder tumor model by using DNA of an alpha antigen from mycobacteria. Kuromatsu I, Matsuo K, Takamura S, Kim G, Takebe Y, Kawamura J, Yasutomi Y. Cancer Gene Ther; 2001 Jul; 8(7):483-90. PubMed ID: 11498769 [Abstract] [Full Text] [Related]
7. [Novel vaccines against M. tuberculosis]. Okada M. Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920 [Abstract] [Full Text] [Related]
9. Effective anti-tumor responses induced by recombinant bacillus Calmette-Guérin vaccines based on different tandem repeats of MUC1 and GM-CSF. Yuan S, Shi C, Han W, Ling R, Li N, Wang T. Eur J Cancer Prev; 2009 Sep; 18(5):416-23. PubMed ID: 19550341 [Abstract] [Full Text] [Related]
13. Immunodominant PstS1 antigen of mycobacterium tuberculosis is a potent biological response modifier for the treatment of bladder cancer. Sänger C, Busche A, Bentien G, Spallek R, Jonas F, Böhle A, Singh M, Brandau S. BMC Cancer; 2004 Nov 26; 4():86. PubMed ID: 15566565 [Abstract] [Full Text] [Related]
18. Expression and immunogenicity of recombinant Mycobacterium bovis Bacillus Calmette-Guérin strains secreting the antigen ESAT-6 from Mycobacterium tuberculosis in mice. Wang LM, Shi CH, Fan XL, Xue Y, Bai YL, Xu ZK. Chin Med J (Engl); 2007 Jul 20; 120(14):1220-5. PubMed ID: 17697571 [Abstract] [Full Text] [Related]
19. The immunotherapeutic effects of recombinant Bacillus Calmette-Guérin resistant to antimicrobial peptides on bladder cancer cells. Cho MJ, Kim MJ, Kim K, Choi YW, Lee SJ, Whang YM, Chang IH. Biochem Biophys Res Commun; 2019 Jan 29; 509(1):167-174. PubMed ID: 30579607 [Abstract] [Full Text] [Related]